Clinical Trials in Suresnes, Île-de-France Region
4 recruiting
Showing 1–4 of 4 trials
Recruiting
Phase 2
Efficacy of Daily IV Administration of Dornase Alfa up to 14 Days Post Subarachnoid Hemorrhage on Functional Independence at 6 Months
SAH (Subarachnoid Hemorrhage)Delayed Cerebral IschemiaRuptured Aneurysm of Intracranial Artery
Fondation Ophtalmologique Adolphe de Rothschild304 enrolled6 locationsNCT06723717
Recruiting
Phase 3
A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
HER2 MutationAdvanced Non-Small Cell Lung Cancer
Bayer444 enrolled283 locationsNCT06452277
Recruiting
Not Applicable
Interest of Late Images for the Assessment of Extensions in 18FGD PET-CT of Muscle-Invasive Bladder Cancers
Muscle-Invasive Bladder CarcinomaBladder Cancer
Hopital Foch66 enrolled1 locationNCT06537960
Recruiting
Not Applicable
Treatment of Chronic Pelvic Pain Due to Endometriosis by Transcutaneous Auricular Vagus Nerve Stimulation
Endometriosis
Hopital Foch72 enrolled1 locationNCT04177511